Positron emission tomography (PET) scan. For a PET scan, a slightly radioactive form of sugar (known as FDG) is injected into the blood and collects mainly in cancer cells. These areas of radioactivity can be seen on a PET scan using a special camera.

article reviews the appropriate role of FDG-PET and FDG-PET-CT imaging in the diagnosis, initial staging, and detection of recurrent disease in pa-tients who have esophageal and gastric cancers.

The study concludes that PET/CT is a crucial diagnostic tool in esophageal cancer patients undergoing radical chemoradiation. It plays a key role in excluding metastatic disease, allowing for appropriate treatment planning.

Jun 1, 2018 · In a recent study, researchers compared the accuracy of PET in 43 patients with cancer of the esophagus to standard staging methods. Initially, these patients underwent computerized tomography (CT) scans and ultrasonography of the esophagus to determine the stage of their cancer.

Nov 1, 2007 · Positron emission tomography (PET)/computed tomography (CT) has important utility and limitations in the initial staging of esophageal cancer, evaluation of response to neoadjuvant therapy, and detection of recurrent malignancy.

Jan 13, 2022 · PET/CT scans are combined to detect cancer and whether it has spread throughout the body. You’ll be injected with a small amount of radioactive sugar to visualize areas of high activity that could be cancer, as the cells take up this substance. Upper endoscopy is one of the most common ways of diagnosing esophageal cancer.

Jun 14, 2023 · Esophageal cancer is a rare cancer that can develop in the tissues of your esophagus. There are no standard early screening tests for people at low risk, but certain symptoms could indicate the...

Feb 23, 2025 · When Stage 4 disease is present, the metastases can be identified using CT or PET scans. Conclusion. Stage 4 esophageal cancer is a serious diagnosis that requires thorough imaging to assess the extent of disease and guide treatment. CT scans, PET-CT, and MRIs provide important information about tumor spread, influencing decisions about ...

Fluorodeoxyglucose (FDG)-positron emission tomography (PET) can provide functional information and is an effective diagnostic modality in esophageal cancer. Its role in the management of esophageal cancer includes staging as well as potential utility in the evaluation of neoadjuvant therapy response and in follow-up after definitive therapy.

Positron emission tomography (PET)/computed tomography (CT) has important utility and limitations in the initial staging of esophageal cancer, evaluation of response to neoadjuvant therapy, and detection of recurrent malignancy.